Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR (Address of principal executive offices, including zip code) Registrant's telephone number, including area code: (801) 253-1600 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Nu ...

Merit Medical Systems, Inc. (NASDAQ:MMSI) Q4 2023 Earnings Conference Call February 28, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman and Chief Executive Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Raul Parra - Chief Financial Officer and Treasurer Conference Call Participants Jason Bednar - Piper Sandler Steve Lichtman - Oppenheimer Jason Bedford - Raymond James John Young - Canaccord Genuity Michael Petusky - Barrington Research Jim Sidoti - Sidoti & Co M ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2023 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (IRS Employer Identi ...

Merit Medical Systems, Inc. (NASDAQ:MMSI) Q3 2023 Earnings Conference Call October 26, 2023 5:00 PM ET Company Participants Fred Lampropoulos – Founder, Chairman and Chief Executive Officer Brian Lloyd – Chief Legal Officer and Corporate Secretary Raul Parra – Chief Financial Officer and Treasurer Conference Call Participants Michael Petusky – Barrington Research Steve Lichtman – Oppenheimer & Co Jayson Bedford – Raymond James Zachary Day – Canaccord Genuity Jim Sidoti – Sidoti & Co Mike Matson – Needham an ...

† A non-GAAP financial measure, representing constant currency revenue, organic. 5 5 In thousands, except percentages | --- | --- | --- | --- | --- | --- | |---------------------|-------|------------------------------------------|-------|-------|--------------| | | | Region Q3 2023 Q3 2022 $ Change % Change | | | CC % Change* | | U.S. | | $187,505 $164,571 $22,934 | | | 13.9% 14.3% | | | | | | | | | APAC | | 59,831 60,175 (344) -0.6% 3.2% | | | | | EMEA | | 55,206 52,060 3,146 6.0% 1.1% | | | | | | | | | | ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. Indicate by check mark whether the registrant has submitted electronically every In ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or other j ...

Merit Medical Systems, Inc. (NASDAQ:MMSI) Q2 2023 Earnings Conference Call July 25, 2023 5:00 AM ET Company Participants Fred Lampropoulos - Chairman and Chief Executive Officer Raul Parra - Chief Financial Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Conference Call Participants Steve Lichtman - Oppenheimer & Company Jayson Bedford - Raymond James Larry Biegelsen - Wells Fargo Jason Bednar - Piper Sandler Mike Matson - Needham & Company Jim Sidoti - Sidoti & Company Michael Petusky - B ...

Merit Medical Investor Call July 25, 2023 Second Quarter 2023 Results Fred Lampropoulos Chairman and CEO | --- ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or other ...